Early research (Phase 1)Ended earlyNCT04653038
What this trial is testing
Evaluate the Safety and Efficacy of MGD013 in Patients With Melanoma
Who this might be right for
Unresectable, Recurrent or Metastatic MelanomaUntreated Mucosal or Acral Lentiginous Melanoma
Zai Lab (Shanghai) Co., Ltd. 92